Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Intensive Follow-up for Bone Metastasis on Characteristics and Prognosis of Chinese Breast Cancer Patients: A Multicenter Retrospective Study

NCT03924609 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT03924609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03924609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Intensive Follow-up for Bone Metastasis on Characteristics and Prognosis of Chinese Breast Cancer Patients: A Multicenter Retrospective Study
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Completed
Start date
March 1, 2018
Completion date
March 31, 2019
Enrollment
1,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, breast cancer